Disc Medicine, Inc. announced it will present data from its hematology portfolio at the European Hematology Association (EHA) 2025 Congress in Milan from June 12-15, 2025. The presentations will ...

Disc Medicine announces positive updates on bitopertin, DISC-0974, and DISC-3405, with plans for upcoming clinical trials and data presentations. Disc Medicine, Inc. recently provided positive updates ...

Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, John Quisel, CEO. Please go ahead. Good morning, and welcome to the ...

Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional ...

WATERTOWN, Mass., Dec. 06, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...

With more than 100,000 implantations worldwide, the M6-C and M6-L discs continue to demonstrate strong clinical performance, safety and patient benefits LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix ...

In addition to Dr. Phillips’s presentation of the five-year IDE trial data, Dr. Avinash Patwardhan, Director of the Musculoskeletal Biomechanics Laboratory at Edward Hines Jr. VA Hospital will present ...

Disc Medicine is also set to present initial data from its RALLY-MF Phase 2 trial of DISC-0974 at the American Society of Hematology Annual Meeting. The presentation will include preliminary results ...

TOKYO – Sony Corp. will launch a new optical disc format in November that allows for storage of up to 23.3GB per disc, the company said Tuesday. The format, called Professional Disc for Data, is being ...

WASHINGTON — Researchers have developed a fast and energy-efficient laser-writing method for producing high-density nanostructures in silica glass. These tiny structures can be used for long-term five ...